Barrington Research Maintains Outperform on HealthEquity, Raises Price Target to $105
Portfolio Pulse from Benzinga Newsdesk
Barrington Research has maintained an Outperform rating on HealthEquity (NASDAQ:HQY) and raised the price target from $100 to $105.
June 04, 2024 | 2:50 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barrington Research has maintained an Outperform rating on HealthEquity and raised the price target from $100 to $105, indicating positive sentiment and potential for stock price appreciation.
The raised price target and maintained Outperform rating from Barrington Research suggest a positive outlook for HealthEquity, likely leading to increased investor confidence and potential short-term stock price appreciation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100